The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5

被引：1

作者：

Liu, Li ^{[1
]}

Wang, Hui-yun ^{[2
]}

Zhou, Xia ^{[1
]}

Zhang, Sheng-Nan ^{[1
]}

Chen, Xiao-Qian ^{[1
]}

Zhao, Feng-Lan ^{[1
]}

Meng, Qing-Guo ^{[1
]}

机构：

[1] Yantai Univ, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Key Lab Mol Pharmacol & Drug Evaluat, Sch Pharm,Minist Educ, Yantai, Peoples R China

[2] Jining Med Univ, Coll Pharm, Rizhao 276826, Peoples R China

来源：

ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES | 2020年 / 235卷 / 06期

基金：

中国国家自然科学基金;

关键词：

OCOTILLOL;

D O I：

10.1515/ncrs-2020-0384

中图分类号：

O7 [晶体学];

学科分类号：

0702 ; 070205 ; 0703 ; 080501 ;

摘要：

C32H52O5, monoclinic, P2(1) (no. 4), a = 11.816(2) angstrom, b = 7.4064(15) angstrom, c = 17.101(3) angstrom, beta = 97.01(3)degrees, V = 1485.5(5) angstrom(3), Z = 2, R-gt(F) = 0.0543, wR(ref)(F-2) = 0.1501, T = 293(2) K.

引用

页码：1547 / 1549

页数：3

共 50 条

[31] (+)-(Z)-(1S,2S,3S,4R,1′S,2′S,3′S,4′R,5′R)-2,3,4-trihydroxy-5-(hydroxymethyl)-N-[2′,3′,4′-trihydroxy-5′-(hydroxymethyl)cyclohex-1′-yl]cyclohex-5-en-1-aminium chloride dihydrate
Chang, HJ
Feng, XL
Zhu, JR
Ng, SW
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : O3839 - O3841
[32] (S)-N-(N-(((2R, 3S, 4R, 5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)sulfamoyl)-5-oxopyrrolidine-2-carboxamide
Khaybullin, Ravil N.
Liang, Xiao
Qi, Xin
MOLBANK, 2015, (02)
[33] Crystal structure of (+)-(4S,5R,2′R,4′S,5′R,1"S)-5-(2"-acetoxy-1"-benzyloxy-ethyl)-3-(5′-acetoxy-2′-methyl-1′,3′-dioxan-4′-yl)-4-(tert-butoxycarbonylamino)-4,5-dihydro-isoxazole, C26H36N2O10
Henkel, S
Fengler-Veith, M
Jäger, V
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2000, 215 (01): : 133 - 134
[34] 2-[(3S, 3aS, 5R, 8S, 8aS)-3,8-Dimethylhexahydro-1H, 4H-3a, 8a- epoxyazulen-5-yl]propan-2-ol
Burrett, Stacey
Taylor, Dennis K.
Tiekink, Edward R. T.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : 0776 - +
[35] Crystal structure of ethyl(-)-(1S,2R,5S,7S,8R,4′S,5′S)-2-methoxy-8-(2′,2′-dimethyl-5′-phenyl-1′,3′-dioxolane-4′-yl)-6-oxo-tricyclo[3.2.1.02,7]octane-1-carboxylate, C23H28O6
Peters, K
Peters, EM
Braun, NA
Klein, I
Spitzner, D
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 1997, 212 (02): : 131 - 132
[36] THE SYNTHESIS OF (2R,3S)-(2S,3R) [4-C-14]AGARIC ACID AND (2R,3R)-(2S-3S) [4,4,5,5-H-3]AGARIC ACID
LELLOUCHE, JP
BEAUCOURT, JP
PICHAT, L
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1984, 21 (02): : 125 - 132
[37] (2S,3R,4S,5R,6S,7R,8R,9S)-1,2,3,4,5,6,7,8,9-NONAACETOXYDECANE
LEWINSKI, K
MARSHALL, JA
BEAUDOIN, S
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1994, 50 : 1366 - 1368
[38] Crystal structure of (5S,4R)-5-(2-oxo-2-phenylethyl)-4-(phenylsulfanyl)2(3H)-dihydrofuranone, C18H16O3S
Spek, AL
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 1997, 212 (02): : 257 - 258
[39] (2S*,4S*,5R*)-4-Methyl-2-[(5S*)-3-methyl-4,5- dihydroisoxazol-5-yl]-5-phenyl-3-(toluene-4-sulfonyl)oxazolidine
Département de Chimie, Univ. du Quebec a Montreal, CP 8888, Succ. Centre-Ville, Montréal, Que. H3C 3P8, Canada
Acta Crystallogr Sect C Cryst Struct Commun, 8 (1373-1375):
[40] STRUCTURE OF (+)-(3S,4R,5R,1'R,2'S,5'R)-TETRACARBONYL((3,4-ETA-2)-5-[5'-METHYL-2'-(1-METHYLETHYL)CYCLOHEXYLOXY]-2(5H)-FURANONE)IRON
ENDERS, D
SCHMITZ, T
RAABE, G
KRUGER, C
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1991, 47 : 37 - 40

← 1 2 3 4 5 →